Precision Medicine News and Research

RSS

Shifting towards precision medicine for type 2 diabetes dietary management

Researchers reviewed existing data on the genetic factors and the gene-diet interactions that could alter dietary management of type 2 diabetes.

8 Jun 2023

AI algorithms outperform the standard clinical risk model for predicting breast cancer risk

In a large study of thousands of mammograms, artificial intelligence (AI) algorithms outperformed the standard clinical risk model for predicting the five-year risk for breast cancer. The results of the study were published in Radiology, a journal of the Radiological Society of North America (RSNA).

6 Jun 2023

SickKids scientists shine light on the complex genetics that underlie blood pressure regulation

Scientists at The Hospital for Sick Children (SickKids) are delving deep into the non-coding genome to unravel the complex genetics that underlie blood pressure regulation and hypertension (high blood pressure) – the leading cause of cardiovascular disease affecting 1.25 billion people worldwide.

6 Jun 2023

COLOTECT 1.0 receives market authorization from Malaysia's Medical Device Authority

Recently, BGI Genomics' COLOTECT 1.0 DNA Methylation Detection Kit for Human SDC2, ADHFE1, and PPP2R5C Genes (Real-Time PCR), Sample Pretreatment Kit for Methylation Detection, DNA Isolation Kit, Stool Sample Collection Kit have received market authorization from Malaysia's Medical Device Authority (hereinafter referred to as MDA).

6 Jun 2023

Research sheds new light on the genetic architecture of bipolar disorder

Bipolar disorder (BD) is a major psychiatric condition that afflicts about 1% of people. Symptoms of BD include sudden onset of depressive mood with loss of interest which alternates with a manic state of hyperactivity.

5 Jun 2023

NCI launches new initiative to test new drug combinations that target specific tumor alterations

The National Cancer Institute (NCI) has launched a large precision medicine cancer initiative to test the effectiveness of treating adults and children with new drug combinations that target specific tumor alterations.

1 Jun 2023

CardioGen upgrade facilitates more accurate diagnosis of monogenic cardiovascular diseases

Over 2,800 cases, representing a 31% increase, added to BGI Genomics-led CardioGen's hereditary cardiovascular disease gene data.

From BGI Genomics 1 Jun 2023

Illinois Tech selected as enrollment site for NIH's landmark initiative to advance nutrition research

Illinois Institute of Technology is one of 14 institutions chosen as an enrollment site for the National Institute of Health's landmark initiative to advance nutrition research.

26 May 2023

Markey one of 71 NCI designated cancer centers in the U.S.

When the University of Kentucky Markey Cancer Center earned a designation the National Cancer Institute (NCI) in 2013, it instantly established Markey as one of the top cancer research centers in the U.S.

26 May 2023

Study examines the role of genetic variants across diverse ancestries in regulating gene expression

Exploring diverse ancestry is a critical factor in furthering medical research.

25 May 2023

Study highlights the genetic basis of cognitive biases in decision making

Have you ever made a decision that, in hindsight, seemed irrational? A new study with mice, which could have implications for people, suggests that some decisions are, to a certain extent, beyond their control.

25 May 2023

Lupus Landmark Study launched to accelerate the development of personalized treatments for lupus patients

The Lupus Research Alliance and its clinical research affiliate Lupus Therapeutics today announced the launch of the Lupus Landmark Study, a groundbreaking observational research study to accelerate the development of personalized treatments for people living with lupus.

24 May 2023

FDA clearance of BU-developed bionic pancreas brings new hope for Americans with type 1 diabetes

A bionic pancreas-;a wearable, pocket-sized, automated insulin delivery device-;that was first developed in a Boston University lab has been cleared by the US Food and Drug Administration (FDA). The iLet Bionic Pancreas is now commercially available, bringing fresh hope to the almost two million Americans with type 1 diabetes.

23 May 2023

Detecting mental disorders with data from wearables

Depression and anxiety are among the most common mental health disorders in the United States, but more than half of people struggling with the conditions are not diagnosed and treated.

23 May 2023

Cardiovascular risk score decreases after one year of semaglutide use in obese patients, study shows

New research presented at this year's European Congress on Obesity in Dublin, Ireland shows that patients treated with the obesity drug semaglutide have a decreased cardiovascular risk score after one year of use.

22 May 2023

Multicenter, 1-year-long real-world study shows effectiveness of semaglutide for weight loss

New research presented at this year's European Congress on Obesity (ECO2023, Dublin, 17-20 May) shows that the obesity drug semaglutide is effective for weight loss in a multicentre, 1-year-long real-world study.

22 May 2023

High-risk heart attack patients could benefit from a long-term treatment with blood thinners

A new study examining the criteria proposed by the European Society of Cardiology (ESC) to prescribe long-term treatment with more than one blood thinner after percutaneous coronary intervention was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions.

19 May 2023

Research paves the way to safer, more effective treatment for children with aggressive blood cancers

Australian nanomedicine researchers have come up with a new approach to solving a decades-old clinical problem: getting treatment drugs to act selectively on cancer cells in the body.

18 May 2023

Every breath counts; Utilizing breath biopsy technology to detect disease early

In this interview, we speak to Mariana Leal, Team Lead at Owlstone Medical, about breath biopsies and how they are a useful tool for investigating biomarkers for the early detection of diseases.

From Owlstone Medical Ltd 17 May 2023

Owlstone Medical Wins Contract from U.S. Department of Defense to Develop Handheld Breath Biopsy Device for Early Infectious Disease Detection

Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced that it had won an award from the U.S. Defense Innovation Unit for ‘Exhaled Breath Diagnostics’.

From Owlstone Medical Ltd 17 May 2023

Precision Medicine News and Research

Shifting towards precision medicine for type 2 diabetes dietary management

AI algorithms outperform the standard clinical risk model for predicting breast cancer risk

SickKids scientists shine light on the complex genetics that underlie blood pressure regulation

COLOTECT 1.0 receives market authorization from Malaysia's Medical Device Authority

Research sheds new light on the genetic architecture of bipolar disorder

NCI launches new initiative to test new drug combinations that target specific tumor alterations

CardioGen upgrade facilitates more accurate diagnosis of monogenic cardiovascular diseases

Illinois Tech selected as enrollment site for NIH's landmark initiative to advance nutrition research

Markey one of 71 NCI designated cancer centers in the U.S.

Study examines the role of genetic variants across diverse ancestries in regulating gene expression

Study highlights the genetic basis of cognitive biases in decision making

Lupus Landmark Study launched to accelerate the development of personalized treatments for lupus patients

FDA clearance of BU-developed bionic pancreas brings new hope for Americans with type 1 diabetes

Detecting mental disorders with data from wearables

Cardiovascular risk score decreases after one year of semaglutide use in obese patients, study shows

Multicenter, 1-year-long real-world study shows effectiveness of semaglutide for weight loss

High-risk heart attack patients could benefit from a long-term treatment with blood thinners

Research paves the way to safer, more effective treatment for children with aggressive blood cancers

Every breath counts; Utilizing breath biopsy technology to detect disease early

Owlstone Medical Wins Contract from U.S. Department of Defense to Develop Handheld Breath Biopsy Device for Early Infectious Disease Detection

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News